相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
L. Y. Dimberg et al.
ONCOGENE (2013)
Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells
In-Ja Park et al.
APOPTOSIS (2012)
New therapeutical strategies in the treatment of metastatic disease
Fanny Julia et al.
DERMATOLOGIC THERAPY (2012)
Utilization of the cellular stress response to sensitize cancer cells to TRAIL-mediated apoptosis
Markus David Siegelin
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
The three Rs along the TRAIL: Resistance, re-sensitization and reactive oxygen species (ROS)
Gregory Mellier et al.
FREE RADICAL RESEARCH (2012)
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
Yong Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation
Yintao Ye et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cells
Ji-Hyun Kim et al.
APOPTOSIS (2011)
Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: Involvement of ROS-dependent ER-stress
Dong-Oh Moon et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation
Y. Yang et al.
ONCOGENE (2011)
Exploring death receptor pathways as selective targets in cancer therapy
Maria Russo et al.
BIOCHEMICAL PHARMACOLOGY (2010)
NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL
Cigdem Aydin et al.
BMC CANCER (2010)
TRAIL receptor signaling and therapeutics
Junaid Abdulghani et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
1α,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells
Anfernee Kai-Wing Tse et al.
MOLECULAR IMMUNOLOGY (2010)
Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells
Wayne Y. W. Lee et al.
CANCER LETTERS (2009)
Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP
Yeoun Hee Kim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response
Makiko Yokouchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
LM Zhou et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation
AKW Tse et al.
BIOCHEMICAL PHARMACOLOGY (2005)
CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells
H Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials
TK Eigentler et al.
LANCET ONCOLOGY (2003)
Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect
JY Seol et al.
CANCER GENE THERAPY (2003)
p53-Independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-γ
RD Meng et al.
EXPERIMENTAL CELL RESEARCH (2001)
Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
R Takimoto et al.
ONCOGENE (2000)